Compare Illumina, Inc. (ILMN) vs Exxon Mobil Corporation (XOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Exxon Mobil Corporation — how do they compare? Illumina, Inc. trades at $180.13 (market cap $27.94B), while Exxon Mobil Corporation trades at $148.49 (market cap $614.94B). The key difference: Exxon Mobil Corporation is far larger — about 22× Illumina, Inc.'s market cap, and Exxon Mobil Corporation pays a 2.78% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | XOM | |
|---|---|---|
Market Cap | $27.94B | $614.94B |
Sector | Health | Energy |
52-Week High | $194.33 | $171.52 |
52-Week Low | $91.00 | $105.83 |
Enterprise Value | $29.33B | $654.17B |
Dividend Yield | — | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
ExxonMobil (XOM) trades at $148.36, up 0.66% with a bullish technical outlook supported by moving averages and strong institutional sentiment. The company maintains solid fundamentals with consistent earnings beats, though revenue has declined from $398.7B in 2022 to $323.9B in 2025. Recent news highlights Exxon's Permian Basin advantages and potential oil price spikes to $150-160 per barrel, while the company's relocation to Texas signals strategic positioning.
XOM presents a balanced investment case with analyst consensus at $169.78 (14% upside) and strong dividend support. Key opportunities include low breakeven Permian operations and natural gas expansion, while risks involve oil price volatility and declining profit margins from 13.98% to 8.9% since 2022. The stock's current valuation at 24.81 P/E appears reasonable given energy sector dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Exxon Mobil Corporation
Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.
Read more on XOM →
